These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9243207)

  • 1. Frequent expression of Fas in gonadotropin-releasing hormone receptor-bearing tumors.
    Imai A; Horibe S; Takagi A; Ohno T; Tamaya T
    Eur J Obstet Gynecol Reprod Biol; 1997 Jul; 74(1):73-8. PubMed ID: 9243207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death.
    Imai A; Takagi A; Horibe S; Takagi H; Tamaya T
    J Clin Endocrinol Metab; 1998 Feb; 83(2):427-31. PubMed ID: 9467552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas and Fas ligand system may mediate antiproliferative activity of gonadotropin-releasing hormone receptor in endometrial cancer cells.
    Imai A; Takagi A; Horibe S; Takagi H; Tamaya T
    Int J Oncol; 1998 Jul; 13(1):97-100. PubMed ID: 9625809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types.
    Imai A; Ohno T; Iida K; Fuseya T; Furui T; Tamaya T
    Cancer; 1994 Nov; 74(9):2555-61. PubMed ID: 7522953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma.
    Ohno T; Imai A; Furui T; Takahashi K; Tamaya T
    Am J Obstet Gynecol; 1993 Sep; 169(3):605-10. PubMed ID: 8103967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of evidence for expression of Fas ligand in Fas-bearing tumors.
    Takagi A; Imai A; Horibe S; Ohno T; Tamaya T
    Oncol Rep; 1998; 5(2):377-80. PubMed ID: 9468561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Fas in female reproductive tract tumors.
    Fuseya T; Imai A; Horibe S; Takagi A; Ohno T; Tamaya T
    Oncol Rep; 1996 Nov; 3(6):1107-9. PubMed ID: 21594518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells.
    Wang Y; Matsuo H; Kurachi O; Maruo T
    Eur J Endocrinol; 2002 Mar; 146(3):447-56. PubMed ID: 11888853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors.
    Imai A; Takagi H; Horibe S; Fuseya T; Tamaya T
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3249-53. PubMed ID: 8784077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for common signalling pathways of GnRH receptor and Fas in tumors.
    Fuseya T; Imai A; Horibe S; Takagi A; Tamaya T
    Oncol Rep; 1996 Nov; 3(6):1111-3. PubMed ID: 21594519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors.
    Farré X; Guillén-Gómez E; Sánchez L; Hardisson D; Plaza Y; Lloberas J; Casado FJ; Palacios J; Pastor-Anglada M
    Int J Cancer; 2004 Dec; 112(6):959-66. PubMed ID: 15386342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral level of gonadotropin-releasing hormone in ovarian and endometrial cancers.
    Furui T; Imai A; Tamaya T
    Oncol Rep; 2002; 9(2):349-52. PubMed ID: 11836606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines.
    Yin H; Cheng KW; Hwa HL; Peng C; Auersperg N; Leung PC
    Life Sci; 1998; 62(22):2015-23. PubMed ID: 9627100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium.
    Imai A; Ohno T; Iida K; Fuseya T; Furui T; Tamaya T
    Gynecol Oncol; 1994 Oct; 55(1):144-8. PubMed ID: 7959256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRH receptor and apoptotic signaling.
    Imai A; Tamaya T
    Vitam Horm; 2000; 59():1-33. PubMed ID: 10714235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor.
    Chatzaki E; Bax CM; Eidne KA; Anderson L; Grudzinskas JG; Gallagher CJ
    Cancer Res; 1996 May; 56(9):2059-65. PubMed ID: 8616851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transforming growth factor alpha mRNA in benign and malignant tissues derived from gynecologic patients with various proliferative conditions.
    Xynos FP; Klos DJ; Hamilton PD; Schuette V; Fernandez-Pol JA
    Anticancer Res; 1992; 12(4):1115-20. PubMed ID: 1323947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells.
    Peng C; Fan NC; Ligier M; Väänänen J; Leung PC
    Endocrinology; 1994 Nov; 135(5):1740-6. PubMed ID: 7956897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone receptor mRNA expression by human pituitary tumors in vitro.
    Alexander JM; Klibanski A
    J Clin Invest; 1994 Jun; 93(6):2332-9. PubMed ID: 8200967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.